0 followers
Lyell is an immuno-oncology company dedicated to reprogramming T cells to achieve curative therapies for solid tumors. The company takes a deliberate approach to solving what it believes to be the major barriers to successful adoptive T cell therapy: T cell exhaustion and loss of durable stemness, w... Read more
Lynn Seely
Roivant Sciences
56 followers
CRISPR Therapeutics
11 followers
Beam
8 followers
ONI
6 followers
Arrowhead Pharmaceuticals
4 followers
Iovance Biotherapeutics
3 followers
Vir Biotechnology
3 followers
Arvinas
3 followers
Recursion Pharmaceuticals
9 followers
Axsome Therapeutics
2 followers
BridgeBio
2 followers
Explore companies